Volume : 12, Issue : 10, October – 2025
Title:
FORMULATION AND EVALUATION OF DULOXETINE HYDROCHLORIDE ENTERIC COATED TABLETS
Authors :
Kadari ramya*, M. Mounika, Dr. D. Venkata ramana.
Abstract :
Objective of the current study is to develop colon targeted drug delivery systems for Duloxetine Hydrochloride. Sodium alginate and Carbopol 940 is used as polymers in this drug delivery system. The colon targeted tablet was prepared by direct compression technique. Study of the preformulation characteristics and FTIR studies indicates that there was no interaction between Duloxetine Hydrochloride and excipients used. The formulated tablets were tested for both pre-compression parameters and post compression parameters as per requirements of standards. Pre-compression parameters such as bulk density, tapped density, compressibility index, Hausner’s ratio and compressibility index. The results obtained indicate that it has good flow property for direct compression. From among the entire batches, formulation F4 showed 98.81% drug release at 24 hrs. Since it provide greater protection to the core under acidic condition while at the same time show the fastest drug release under intestinal pH. So the trial F4 was considered as best formulation.
Keywords: Duloxetine Hydrochloride, Sodium alginate, Carbopol 940, and colon targeted drug delivery systems
Cite This Article:
Please cite this article in press Kadari Ramya et al., Formulation And Evaluation Of Duloxetine Hydrochloride Enteric Coated Tablets, Indo Am. J. P. Sci, 2025; 12(10).
REFERENCES:
1. Ansel H, Allen L and Jr. Popovich N. Ansel’s Pharmaceutical Dosage Forms and Drug delivery systems, Baltimore, Md: Lippincott Williams & Wilkins. 8th edition, 2004; p.g 260- 268.
2. Leon Lachmann, Herbert A. Liberman, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy.Varghese publishing House,Bombay, 3rd edition, 1998: p.g. 171, 201- 213, 285-286, 293, 313-314, 400-456.
3. Chien Y.W. Novel Drug Delivery Systems. Revised and expanded, 2nd edition: 1992: p.g 1-2, 139-140.
4. Mehta R.M. Pharmaceutics-1.Vallabh Prakashan, 3rd Edition New Delhi: 2002: p.g. 238-239.
5. Indian pharmacopoeia. The Indian Pharmacopoeia Commission.Ghaziabad: 2007 Vol.2 p.g 662.
6. Debjit Bhowmik. Tablet manufacturing processs and defects of tablets, Elixir Pharmacy 70 (2014) p.g. 24368-24374.
7. Leon Lachmann, Herbert A. Lieberman, Joseph L. Kanig, The Theory and Practice of Industrial Pharmacy, New Delhi,CBS publishers, 4th edition,2006: p.g. 293-303.
8. David Jones, Pharmaceutics Dosage form and Design,. Pharmaceutical Press London, Chicago, 2008, 1st edition p.g: 227.
9. Gilbert.S.Banker, Christopher. T.Rhodes, Modern Pharmaceutics, 4th edition, NewYork. Basel, 1980, p.g:17.
10. Lachman.L, Liberman H.A, Joseph L Kanig. The Theory and Practice of Industrial pharmacy. Varghese publishing house, New Delhi, 3rdedition, 1989; p.g. 331-332.
11. James.W, Linda A.F. Aqueous Polymeric Coating for Pharmaceutical Dosage forms. Taylor and Francis, p.g.327.
12. Alford N Martin, Patrick J. Sinko. Martin’s Physical pharmacy and pharmaceutical sciences, Lippincott Williams & Wilkins. 6th edition 2006.p.g 302
13. Lachman.L, Lieberman H.A, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy, Varghese publishing house, 3rd edition, 1990; p.g 346.
14. Sayed I. Abdel-Rahman, Gamal M.M, El-Badry M, Preparation and Comparative Evaluation of Sustained Release Metoclopramide Hydrochloride Matrix Tablets, Saudi Pharmaceutical Journal ,2009 ; 17: p.g 283-288.
15. Chandran S, Laila F.A and Mantha N, Design and Evaluation of Ethyl Cellulose Based Matrix Tablets of Ibuprofen with pH Modulated Release Kinetics, Indian Journal of Pharmaceutical Sciences, September-October 2008.
16. Gothi G.D, Parinh B.N, Patel T.D, Prajapati S.T, Patel D.M, Patel C.N, Journal of Global Pharma Technology, 2010; 2(2):p.g 69-74.
17. Basak S.C, Reddy J.B.M, and Lucas Mani K.P. Indian Journal of Pharmaceutical Sciences, September-October 2006.
18. Varshosaz J, Tavakoli .N and Kheirolahi. A.A.P.S PharmSciTech, 2006; 7(1).
19. Raghvengra Rao N.G, Gandhi S, and Patel T. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(1).
20. Shivhare U.D, Adhao N.D, Dr. Bhusari K.P, Dr. Mathur V.B and Ambulkar U.D. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(2).
21. Vyas S.P, Khar R.K. Controlled Drug Delivery: Concepts and Advances. 1st edition. Vallabh Prakashan, 2002:p.g.156-189.
22. Brahmankar H.A, Jaiswal S.B, Biopharmaceutics and Pharmacokinetics a Treatise, Vallabh Prakashan, 2000, p.g 348-357 and 337.
23. Wani M.S, Controlled Release System- A Review, 2008, 6 (1), www.pharmainfo.net/review.
24. Philip A.K, Dabas S, Pathak K. Optimized Prodrug Approach: A means for achieving enhanced Anti-inflammatory Potential in Experimentally Induced Colitis. Journal of Drug Target 2009; p.g 17:235-241.